Company News
Aurobindo Pharma Transfers Domestic Business to Subsidiary
Aurobindo Pharma's board approved the slump sale of its domestic branded generics business to its wholly-owned subsidiary, Auropharm Limited, for INR 143.21 crore.
The transaction, executed on April 6
